Share this article Share this article The successful British scale-up has attracted senior figures in international business development, pharmaceutical commercial strategy and nutrition innovation in San Diego, Cambridge Massachusetts, and New York to help shape the next phase of its worldwide growth CAMBRIDGE, United Kingdom, May 11, 2021 /PRNewswire/ -- Eagle Genomics, a pioneer in applying network science to biology, has announced the appointment of three prestigious US-based advisory board members to its global panel, to help shape the next phase of its growth internationally. The move comes as the world's biggest brands in food, personal care and agriculture biotechnology (AgBio) look to play their part in addressing real-world challenges with innovative, sustainable, next-generation products that work symbiotically with the microbiome.